Dilemmas Encountered by Small and Medium-sized Orthopedic Medical Device Manufacturing Companies in Healthcare Reform Based on a Supply Chain Perspective: Taking a Manufacturer in Jiangsu Province as an Example
DOI:
https://doi.org/10.54691/bcpbm.v42i.4564Keywords:
Orthopedic instrument; Healthcare reform; Volume-based procurement; Supply chain.Abstract
As China’s healthcare reform progresses, the medical device industry is receiving significant attention as an essential part of the healthcare delivery system. Current research on the supply and management of medical devices in the context of healthcare reform mainly focuses on the downstream of the supply chain to innovate the management model of orthopedic consumables in hospitals and realize competent healthcare. However, only a few studies have focused on medical device manufacturers upstream of the supply chain and proposed measures to improve supply chain performance. This paper takes a medium-sized customer medical device manufacturer in China as a case study. This study analyzes the problems revealed in its supply chain operation through literature research, case study analysis, and fieldwork. It proposes countermeasures for the continuous improvement of the industry against the background of healthcare reform. The study found that small and medium-sized medical device manufacturers were not using management information systems adequately and were suffering from the impact of healthcare reform by sticking to their old distribution models. For long-term growth, these small and medium-sized medical companies should focus on research and development, cater to market needs, integrate downstream distributors, and work with hospitals to establish a more transparent and efficient healthcare supply chain.
Downloads
References
State Council of the People’s Republic of China. State Council on issuing the "Thirteenth Five-Year Plan" to deepen Notice on the Plan for Deepening the Reform of the Medical and Health System. December 27, 2017. Retrieved on September 17, 2022. Retrieved from: http://www.gov.cn/zhengce/content/2017-01/09/content_5158053.htm
Yue Cao, Zhaojun Guo. Analysis of the Acceptance Review Requirements for Medical Device Product Registration and Change Registration Under the New Regulatory System. Evaluation and Supervision, 2022, 7: 1-4.
Haiyan Zheng, Jingwen Guo, Xiao Lian, et al. Medical device unique identifier (UDI) related regulations. China AUTO-ID, 2022,86(5): 73-78.
National Medical Products Administration. Interpretation of the “Rules for the Unique Medical Device Identification System.” September 27, 2019. Retrieved on September 17, 2022. Retrieved from: https://www.nmpa.gov.cn/xxgk/zhcjd/zhcjdylqx/20190827104001812.html
Weixue Chang. A Preliminary Study on the Construction of Internal Control Information System for Small and Medium Enterprises. China Circulation Economy, 2022,4: 31-33.
Yanbo Zuo, Jie Xu. Computer vision-based automatic identification technology solves orthopedic consumables management pain points. China AUTO-ID, 2021,93(6): 63-66.
Shuyun Zhou. Centralized quantity-based procurement becomes normalized and institutionalized. Over 260 billion yuan in savings over the past three years from state organizations’ collective procurement. February 12, 2022. Retrieved on September 17, 2022. Retrieved from: http://www.gov.cn/zhengce/2022-02/12/content_5673241.htm
Hongyu Gao. An example is the discussion and practice of building an intelligent supply chain system for commercial distribution enterprises taking orthopaedic medical device products. SUPPLY CHAIN MANAGEMENT, 2022,2: 78-84.
General Office of the State Council, PRC. Opinions of the General Office of the State Council on promoting the regular and institutionalized implementation of centralized quantity procurement of drugs. January 22, 2021. Retrieved on September 20, 2022. Retrieved from: http://www.gov.cn/gongbao/content/2021/content_5585228.htm
Chechen Zheng, Yaodong Zhang, Weiyang Sun, et al. Study on the rules of quantity procurement of orthopaedic medical consumables in six provinces in China. CHINA HEALTH INSURANCE, 2021, 7:51-55.






